FCAS Cancellation a Non-Event for Airbus, mwb Research Says

Germany and France’s move to cancel the manned fighter jet at the center of the Future Combat Air System program will have negligible earnings impact on Airbus (EPA: AIR), according to mwb Research, which kept its Hold rating and unchanged price target of 180 euros on the shares in a note to clients.

Analyst Jens-Peter Rieck said the headline 100 billion euro figure attached to FCAS “refers to lifetime program cost across several nations over decades, not near-term Airbus revenue,” adding that the program never advanced beyond demonstrator work and that service entry was a “2040+ story.”

Against Airbus Defence and Space full-year 2025 revenue of approximately 13.4 billion euros, mwb Research said the contribution to the current top line “is a rounding error.”

Strategically, mwb Research characterised the cancellation as “neutral to marginally positive,” noting that the collapse removes a longstanding industrial overhang while combat cloud and drone elements may continue.

The firm said it treats the development as “an overhang removed rather than a reason to revisit estimates.”

Rieck flagged a potential read-across for Rheinmetall and KNDS via the Main Ground Combat System program, which “could come under renewed scrutiny if Franco German defence cooperation deteriorates further.” One potential MGCS supplier, the firm noted, does not expect that program to proceed.

For Airbus, mwb Research said the investment case remains anchored to commercial aircraft deliveries and engine supply constraints. The firm holds its fiscal 2026 delivery estimate at 860 units against guidance of approximately 870, with Pratt & Whitney supply remaining the binding constraint, and still expects a formal guidance trim.